JOHN A. MORAN EYE CENTER RESEARCH: The Science of Hope

From Idea To Treatment

Moran invests in the full spectrum of research, supporting basic research that adds to our foundation of knowledge and then providing the tools to translate discoveries into new therapies and treatments.

How are Moran researchers helping patients?

Better Medical Devices

Iqbal "Ike" K. Ahmed, MD, FRCSC, is vetting the latest micro-invasive surgical devices used during glaucoma surgery.

Bradley J. Katz, MD, PhD, designed a special coating applied to eyeglasses that blocks a wavelength of light that can trigger migraines.

Barbara Wirostko, MD, developed a polymer into an ocular bandage gel to treat eye trauma.

New Understanding

From hunting for genes implicated in blinding conditions to mapping the brain to understand how vision occurs, Moran researchers are on the leading edge of basic research.

New Drug Therapies

David Krizaj, PhD, invented a unique pressurereducing drug designed to protect retinal cells for millions of glaucoma patients facing vision loss.

Gregory S. Hageman, PhD, is developing new treatments for AMD after discovering it is at least t wo biologically distinct diseases.

Paul Bernstein, MD, PhD, was part of the national effort that developed the widely used Age-Related Eye Disease Study (AREDS) supplement formulation for age-related macular degeneration.

Clinical Trials

Moran patients can participate in a variety of clinical trials that test cutting-edge treatments, from the latest techniques in laser-assisted vision correction surgery to dietary changes that may delay the onset of eye disease.